Covenant Partners, LLC Astrazeneca PLC Transaction History
Covenant Partners, LLC
- $337 Million
- Q1 2024
A detailed history of Covenant Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Covenant Partners, LLC holds 11,737 shares of AZN stock, worth $930,039. This represents 0.24% of its overall portfolio holdings.
Number of Shares
11,737
Previous 11,704
0.28%
Holding current value
$930,039
Previous $788,000
0.89%
% of portfolio
0.24%
Previous 0.25%
Shares
15 transactions
Others Institutions Holding AZN
# of Institutions
1,258Shares Held
480MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.86 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.89 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.4 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.74 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.37 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $246B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...